Bioequivalence Study of WP205 in Healthy Subjects

PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 15, 2025

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions

Therapeutic Equivalency, Healthy

Interventions

DRUG

Methylconalamin Injection(WP205)

25 mg intramuscular injection in the upper-arm deltoid

DRUG

Methylconalamin for Injection

25 mg intramuscular injection in the upper-arm deltoid

All Listed Sponsors

lead

Wanbangde Pharmaceutical Group Co., LTD

INDUSTRY